Pharmacyte Biotech Inc is a biotechnology company focused on developing innovative therapies for the treatment of cancer and other serious diseases
The company's primary platform involves utilizing its proprietary cell encapsulation technology, which aims to enhance the effectiveness of existing treatments and create new treatment modalities. By leveraging this technology, Pharmacyte seeks to provide targeted therapies designed to optimize patient outcomes and improve quality of life. The company is actively engaged in research and clinical development to advance its therapeutic candidates and bring them to market.
Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) stock moved upwards by 16.8% to $1.32 during Friday's after-market session. The company's market cap stands at $37.0 million.
Gainers
Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares...
PharmaCyte Biotech Inc (NASDAQ: PMCB) updated its activities to lift the FDA's clinical hold on PharmaCyte's treatment for locally advanced, inoperable...
Gainers
Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc...
Gainers
Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7...
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the...
PharmaCyte Biotech Inc (NASDAQ: PMCB) stock is moving higher in reaction to the first test results of the biocompatibility studies of its CypCaps trial product candidate.
These...
Gainers
IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic...
Gainers
IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in...
The stock price of PharmaCyte Biotech Inc (NASDAQ: PMCB) is trading higher during premarket today.
Investors are expecting a major announcement from the company...
Gainers
Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The company's market cap stands at $51.7 million.
Cardiff...
Gainers
Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,...
Gainers
Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value...
Gainers
Greenpro Capital Corp. (NASDAQ: GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X...
Gainers
GeoVax Labs, Inc.. (NASDAQ: GOVX) shares rose 72.1% to $7.40 in pre-market trading after the company announced it presented COVID-19 vaccine data at the European Society...
Toward the end of trading Thursday, the Dow traded down 0.49% to 34,790.15 while the NASDAQ fell 0.07% to 14,515.39. The S&P also fell, dropping 0.14% to 4,394.20.
The U....
Gainers
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 63.7% to close at $1.22 on Thursday after dropping 12% on Wednesday. Sonnet BioTherapeutics recently...
Gainers
Sonnet BioTherapeutics (NASDAQ:SONN) shares moved upwards by 110.49% to $1.57 during Thursday's regular session. Trading volume for Sonnet BioTherapeutics'...
Midway through trading Thursday, the Dow traded down 0.40% to 34,819.43 while the NASDAQ rose 0.07% to 14,535.52. The S&P also fell, dropping 0.03% to 4,398.74.
The U.S. has...
